Range Capital Acquisition (RANG) Liabilities and Shareholders Equity (2024 - 2026)
Range Capital Acquisition (RANG) posted Liabilities and Shareholders Equity of $121.7 million for Q1 2026, up 0.67% sequentially from $120.9 million in Q4 2025, and up 3.37% YoY from $117.8 million in Q1 2025.
Range Capital Acquisition (RANG) Liabilities and Shareholders Equity (2024 - 2026) Analysis & Trends
Range Capital Acquisition has reported Liabilities and Shareholders Equity for 3 years, with the latest figure at $121.7 million in Q1 2026.
- Quarterly Liabilities and Shareholders Equity rose 3.37% year-over-year to $121.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $481.4 million (changed N/A YoY) and the FY2025 annual result came in at $120.9 million, up 18.9% from the prior year.
- Liabilities and Shareholders Equity rose to $121.7 million in Q1 2026 per RANG's latest filing, from $120.9 million in the prior quarter.
- Over five years, Liabilities and Shareholders Equity peaked at $121.7 million in Q1 2026 and troughed at $101.7 million in Q4 2024.
- A 3-year average of $116.8 million and a median of $119.4 million in 2025 frame the typical range for Liabilities and Shareholders Equity.
- The sharpest annual moves came in 2025 and 2026: Liabilities and Shareholders Equity climbed 18.9% in 2025, then climbed 3.37% in 2026.
- Over 3 years, Liabilities and Shareholders Equity stood at $101.7 million in 2024, then rose by 18.9% to $120.9 million in 2025, then advanced by 0.67% to $121.7 million in 2026.
- According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $121.7 million, $120.9 million, and $119.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Oxley Bridge Acquisition | 585.76 Mn | 585.76 Mn | - | 261.48 Mn |
| 2 | Launch Two Acquisition | 557.86 Mn | 557.86 Mn | - | 245.80 Mn |
| 3 | Drugs Made In America Acquisition | 507.00 Mn | 507.00 Mn | - | 514.10 Mn |
| 4 | Cantor Equity Partners IV | 468.00 Mn | 468.00 Mn | - | 464.99 Mn |
| 5 | GP-Act III Acquisition | 401.06 Mn | 401.06 Mn | - | 98.35 Mn |
| 6 | Aldel Financial | 397.49 Mn | 397.49 Mn | - | 247.73 Mn |
| 7 | Republic Digital Acquisition | 389.25 Mn | 388.51 Mn | - | 314.37 Mn |
| 8 | Gores Holdings X | 385.06 Mn | 384.87 Mn | - | 374.60 Mn |
| 9 | Agriculture & Natural Solutions Acquisition | 377.29 Mn | 377.04 Mn | - | 376.80 Mn |
| 10 | Range Capital Acquisition | 109.69 Mn | 109.69 Mn | - | 23.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 23.24 Mn |
| Mar 31, 2026 | 121.73 Mn |
| Dec 31, 2025 | 120.93 Mn |
| Sep 30, 2025 | 119.91 Mn |
| Jun 30, 2025 | 118.83 Mn |
| Mar 31, 2025 | 117.77 Mn |
| Dec 31, 2024 | 101.71 Mn |